Logotype for Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals (SUPN) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Supernus Pharmaceuticals Inc

Proxy filing summary

30 Apr, 2026

Voting matters and shareholder proposals

  • Election of two directors, Frederick M. Hudson and Charles W. Newhall, III, for three-year terms is proposed, with board recommendation to vote FOR both nominees.

  • Advisory (non-binding) vote on executive compensation is included, with board recommendation to vote FOR.

  • Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026, is proposed, with board recommendation to vote FOR.

  • Proposal to amend the 2021 Equity Incentive Plan to increase the number of shares available under the plan, with board recommendation to vote FOR.

Board of directors and corporate governance

  • Board recommends all proposals and nominees, indicating unified governance support for the agenda.

Executive compensation and say-on-pay

  • Shareholders are asked to approve, on a non-binding basis, the compensation paid to named executive officers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more